Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”

Chen, Wenjia, Tran, Trung N., Sadatsafavi, Mohsen, Murray, Ruth B., Boon Wong, Nigel Chong, Ali, Nasloon, Ariti, Con, Bulathsinhala, Lakmini, Garcia Gil, Esther, FitzGerald, J. Mark, Alacqua, Marianna, Al-Ahmad, Mona, Altraja, Alan, Al-Lehebi, Riyad, Bhutani, Mohit, Bjermer, Leif, Bjerrum, Anne-Sofie, Bourdin, Arnaud, von Bülow, Anna, Busby, John, Canonica, Giorgio Walter, Carter, Victoria, Christoff, George C., Cosio, Borja G., Costello, Richard W., Fonseca, João A., Gibson, Peter G., Yoo, Kwang Ha, Heaney, Liam G., Heffler, Enrico, Hew, Mark, Hilberg, Ole, Hoyte, Flavia, Iwanaga, Takashi, Jackson, David J., Jones, Rupert C., Koh, Mariko Siyue, Kuna, Piotr, Larenas-Linnemann, Désirée, Lehmann, Sverre, Lehtimäki, Lauri, Lyu, Juntao, Mahboub, Bassam, Maspero, Jorge, Menzies-Gow, Andrew N., Newell, Anthony, Sirena, Concetta, Papadopoulos, Nikolaos G., Papaioannou, Andriana I., Perez-de-Llano, Luis, Perng (Steve), Diahn-Warng, Peters, Matthew J., Pfeffer, Paul E., Porsbjerg, Celeste M., Popov, Todor A., Rhee, Chin Kook, Salvi, Sundeep, Taillé, Camille, Taube, Christian, Torres-Duque, Carlos A., Ulrik, Charlotte, Ra, Seung Won, Wang, Eileen, Wechsler, Michael E. and Price, David B. (2024) Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”. The Journal of Allergy and Clinical Immunology: In Practice, 12 (2). pp. 536-539. ISSN 22132198

Text Reply to Exploring the long-term effects of biologic initiation in severe asthma Insights from the International Severe Asthma Registry.pdf Restricted to Repository staff only Available under License Creative Commons Attribution. Download (161kB) | Request a copy

Abstract

To the Editor: We agree with many points made by Cheng et al1 and offer our clarifications. We agree that severe asthma is heterogeneous, and unraveling asthma phenotypes and endotypes can pave the way for precision medicine in asthma management, which is within the scope of the International Severe Asthma Registry (ISAR). The referenced GLITTER study was focused on a more severe subgroup of patients who had guideline-defined severe asthma and high exposure to oral corticosteroids (OCS).2

Item Type:	Article
Depositing User:	Ms Raisa Burton
Date Deposited:	15 Feb 2024 13:07
Last Modified:	17 Sep 2026 11:26
URI:	https://marjon.repository.guildhe.ac.uk/id/eprint/17797

Actions (login required)

Edit Item